| http://www.w3.org/ns/prov#value | - Other common toxicities related to panitumumab treatment, such as diarrhea and hypomagnesaemia, should be closely monitored to ensure early treatment or substitution.Related: Monoclonal Antibodies Colorectal (Bowel) Cancer Panitumumab (Vectibix) Price TJ, Peeters M, Kim TW, et al.Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cance
|
